Anticoagulation of pediatric patients with venous thromboembolism in 2023

Venous thromboembolism (VTE) is a rare and heterozygous disease in children. Management of VTE in children is complicated by age-related differences in epidemiology, recurrent VTE and bleeding risk, hemostatic proteins and pharmacokinetics of anticoagulants. Recently, the choice of anticoagulation h...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Thrombosis research 2024-03, Vol.235, p.186-193
Hauptverfasser:	van Ommen, C. Heleen, Luijnenburg, Saskia E.
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Anticoagulants - therapeutic use Child Hemostatics Heparin Humans Infant Infant, Newborn Oral factor IIa inhibitor Oral factor Xa inhibitor Pediatrics Secondary Prevention Venous thromboembolism Venous Thromboembolism - drug therapy Vitamin K antagonist
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!